Erythromycin as a potential precipitating agent in the onset of Leber's hereditary optic neuropathy

Mitochondrion

Volumn 4, Issue 1, 2004, Pages 31-36

  Luca, Corneliu C ^a   Lam, Byron L ^a   Moraes, Carlos T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Erythromycin; Leber's hereditary optic neuropathy; Transmitochondrial cybrids

Indexed keywords

ANTIBIOTIC AGENT; CETIRIZINE; ERYTHROMYCIN; HISTAMINE H1 RECEPTOR ANTAGONIST; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ARTICLE; BIOENERGY; CASE REPORT; CELL RESPIRATION; CLINICAL TRIAL; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; OPTIC NERVE ATROPHY; OSTEOSARCOMA CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY CHAIN; VISUAL IMPAIRMENT;

EID: 23744471642     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2004.05.002     Document Type: Article

References (29)

1. Andersson, S.G., Kurland, C.G., 1999. Origins of mitochondria and hydrogenosomes. Curr. Opin. Microbiol. 2, 535-541.
2. Bacino, C., Prezant, T.R., Bu, X., Fournier, P., Fischel-Ghodsian, N., 1995. Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness. Pharmacogenetics 5, 165-172.
3. Carelli, V., Giordano, C., D'amati, G., 2003. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 19, 257-262.
4. Chomyn, A., 1996a. In vivo labeling and analysis of human mitochondrial translation products. Methods Enzymol. 264, 197-211.
5. Chomyn, A., 1996b. Platelet-mediated transformation of human mitochondrial DNA-less cells. Methods Enzymol. 264, 334-339.
6. Davis, B.D., 1987. Mechanism of bactericidal action of amino-glycosides. Microbiol. Rev. 51, 341-350.
7. Doersen, C.J., Stanbridge, E.J., 1979. Cytoplasmic inheritance of erythromycin resistance in human cells. Proc. Natl Acad. Sci. USA 76, 4549-4553.
8. Fischel-Ghodsian, N., 1999. Genetic factors in aminoglycoside toxicity. Ann. NY Acad. Sci. 884, 99-109.
9. Fischel-Ghodsian, N., 2003. Mitochondrial deafness. Ear. Hear. 24, 303-313.
10. Fischel-Ghodsian, N., Prezant, T.R., Bu, X., Oztas, S., 1993. Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity. Am. J. Otolaryngol. 14, 399-403.
11. Ghelli, A., Zanna, C., Porcelli, A.M., Schapira, A.H., Martinuzzi, A., Carelli, V., Rugolo, M., 2003. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J. Biol. Chem. 278, 4145-4150.
12. Harding, A.E., Riordan-Eva, P., Govan, G.G., 1995. Mitochondrial DNA diseases: genotype and phenotype in Leber's hereditary optic neuropathy. Muscle Nerve 3, S82-S84.
13. Hotta, Y., Fujiki, K., Hayakawa, M., Nakajima, A., Kanai, A., Mashima, Y., et al., 1995. Clinical features of Japanese Leber's hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn. J. Ophthalmol. 39, 96-108.
14. Inoue, K., Takai, D., Soejima, A., Isobe, K., Yamasoba, T., Oka, Y., et al., 1996. Mutant mtDNA at 1555 A to G in 12S rRNA gene and hypersusceptibility of mitochondrial translation to streptomycin can be co-transferred to rho 0 HeLa cells. Biochem. Biophys. Res. Commun. 223, 496-501.
15. Kerrison, J.B., Newman, N.J., 1997. Clinical spectrum of Leber's hereditary optic neuropathy. Clin. Neurosci. 4, 295-301.
16. King, M.P., Attadi, G., 1996. Mitochondria-mediated transformation of human rho(0) cells. Methods Enzymol. 264, 313-334.
17. Lewis, W., Dalakas, M.C., 1995. Mitochondrial toxicity of antiviral drugs. Nat. Med. 1, 417-422.
18. Mackey, D.A., Fingert, J.H., Luzhansky, J.Z., Mccluskey, P.J., Howell, N., Hall, A.J., et al., 2003. Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus. Eye 17, 312-317.
19. Man, P.Y., Turnbull, D.M., Chinnery, P.F., 2002. Leber hereditary optic neuropathy. J. Med. Genet. 39, 162-169.
20. Mashima, Y., Hiida, Y., Oguchi, Y., 1995. Lack of differences among mitochondrial DNA in family members with Leber's hereditary optic neuropathy and differing visual outcomes. J. Neuroophthalmol. 15, 15-19.
21. Moraes, C.T., Dimauro, S., Zeviani, M., Lombes, A., Shanske, S., Miranda, A.F., et al., 1989. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J. Med. 320, 1293-1299.
22. Moraes, C.T., Atencio, D.P., Oca-Cossio, J., Diaz, F., 2003. Techniques and pitfalls in the detection of pathogenic mitochondrial DNA mutations. J. Mol. Diagn. 5, 197-208.
23. Robinson, B.H., 1996. Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. Methods Enzymol. 264, 454-464.
24. Sadun, A.A., Carelli, V., Salomao, S.R., Berezovsky, A., Quiros, P., Sadun, F., et al., 2002. A very large Brazilian pedigree with 1 1778 Leber's hereditary optic neuropathy. Trans Am. Ophthalmol. Soc. 100, 169-178.(discussion 178-179).
25. Sadun, A.A., Carelli, V., Salomao, S.R., Berezovsky, A., Quiros, P.A., Sadun, F., et al., 2003. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am. J. Ophthalmol. 136, 231-238.
26. Simons, F.E., 1994. H1-receptor antagonists. Comparative tolerability and safety. Drug Saf. 10, 350-380.
27. Tok, J.B., Bi, L., 2003. Aminoglycoside and its derivatives as ligands to target the ribosome. Curr. Top. Med. Chem. 3, 1001-1019.
28. Wallace, D.C., Singh, G., Lott, M.T., Hodge, J.A., Schurr, T.G., Lezza, A.M., et al., 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242, 1427-1430.
29. Warner, R.B., Lee, A.G., 2002. Leber hereditary optic neuropathy associated with use of ephedra alkaloids. Am. J. Ophthalmol. 134, 918-920.